Revolution Medicines Inc (NASDAQ:RVMD)

Delayed Data
As of Sep 17
 +1.33 / +4.44%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Revolution Medicines Inc have a median target of 34.00, with a high estimate of 38.00 and a low estimate of 27.00. The median estimate represents a +8.70% increase from the last price of 31.28.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Revolution Medicines Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -5.83%
Growthannually -21.72%


Growthquarterly -2.47%
Growthannually -16.99%
Key to the earnings and sales forecast charts.